I Have a Medical Degree. Should I Consider a Career in Clinical Pharmacology in 2026?

Physicians have become increasingly rare in academic clinical pharmacology.This Perspective examines the structural, educational, and financial reasons behind this decline, contrasting the United States with publicly funded health systems.It argues that clinical pharmacology practiced by physicians remains alive but dispersed and discusses what physicians bring to the discipline and what it would take to make this career visible and attractive again.During my medical studies, I do not recall a single classmate saying that their dream was to become a clinical pharmacologist.Like many others, I was drawn instead to neurosurgery, a more fashionable specialty.I ended up in a discipline that draws far less attention at family dinners but makes me feel useful to my patients and my hospital.What is often seen as an anomaly in a medical career actually has a lot to offer.So, what does an MD bring to clinical pharmacology, and why has that combination become something of an endangered species in the field?After training in internal medicine and in clinical pharmacology and toxicology in Switzerland, I am now completing a research fellowship in the United States.What strikes me here, as it already did in Europe, though to a lesser extent, is how

Authors

Institutions

Publication Details

Journal
Clinical Pharmacology & Therapeutics
Published
2026-11-06
DOI
https://doi.org/10.1002/cpt.70564
Primary Topic
Health and Medical Research Impacts
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

I Have a Medical Degree. Should I Consider a Career in Clinical Pharmacology in 2026?

Jean Terrier
Clinical Pharmacology & Therapeutics
Health and Medical Research Impacts
article

I Have a Medical Degree. Should I Consider a Career in Clinical Pharmacology in 2026?

Jean Terrier
article en

Abstract

Physicians have become increasingly rare in academic clinical pharmacology.This Perspective examines the structural, educational, and financial reasons behind this decline, contrasting the United States with publicly funded health systems.It argues that clinical pharmacology practiced by physicians remains alive but dispersed and discusses what physicians bring to the discipline and what it would take to make this career visible and attractive again.During my medical studies, I do not recall a single classmate saying that their dream was to become a clinical pharmacologist.Like many others, I was drawn instead to neurosurgery, a more fashionable specialty.I ended up in a discipline that draws far less attention at family dinners but makes me feel useful to my patients and my hospital.What is often seen as an anomaly in a medical career actually has a lot to offer.So, what does an MD bring to clinical pharmacology, and why has that combination become something of an endangered species in the field?After training in internal medicine and in clinical pharmacology and toxicology in Switzerland, I am now completing a research fellowship in the United States.What strikes me here, as it already did in Europe, though to a lesser extent, is how

Clinical Pharmacology & Therapeutics
University of Rhode Island (US), University Hospital of Geneva (CH)
Good health and well-being
Openalex Percentile: Top 12%
Health and Medical Research Impacts
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon